This informal session provides the perfect opportunity to connect with the industry

frontrunners and key opinion leaders focusing on fibrosis across the lung, liver, kidney, cardiac, gastrointestinal and scleroderma landscapes.

Establish meaningful connections to build upon for the rest of the conference and gain exclusive first-hand insights into the latest research and developments driving progression across the cross-fibrosis disease field.